References
- Drummond MF, O’Brien BJ, Stoddart GL, et al. Methods for the economic evaluation of health care programs. New York: Oxford University Press Inc.; 2001
- Coons SJ, Rao S, Keininger DL, et al. A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000;17:13–35
- Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989;27: S217–32
- Kaplan RM, Anderson JP. A general health policy model: update and applications. Health Serv Res 1988;23:203–35
- Horsman J, Furlong W, Feeny D, et al. The Health Utilities Index (HUI[R]): concepts, measurement properties and applications. Health Qual Life Outcomes 2003;1:54
- Furlong WJ, Feeny DH, Torrance GW, et al. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001;33:375–84
- Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53–72
- Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337–43
- Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21: 271–92
- Fortin M, Lapointe L, Hudon C, et al. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes 2004;2:51
- Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002;288:1775–9
- Lethbridge-Çejku M, Vickerie J. Summary health statistics for U.S. adults: National Health Interview Survey, 2003. National Center for Health Statistics. Vital Health Stat 2005;10: 1–161
- Alonso J, Ferrer M, Gandek B, et al. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res 2004;13:283–98
- Mittmann N, Trakas K, Risebrough N, et al. Utility scores for chronic conditions in a community-dwelling population. Pharmacoeconomics 1999;15:369–76
- Schultz SE, Kopec JA. Impact of chronic conditions. Health Rep 2003;14:41–53
- Mo F, Choi BC, Li FC, et al. Using Health Utility Index (HUI) for measuring the impact on health-related quality of life (HRQL) among individuals with chronic diseases. ScientificWorldJournal 2004;4:746–57
- Lubetkin EI, Jia H, Franks P, et al. Relationship among socio-demographic factors, clinical conditions, and health-related quality of life: examining the EQ-5D in the U.S. general population. Qual Life Res 2005;14:2187–96
- Sullivan PW, Lawrence WF, Ghushchyan V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care 2005;43:736–49
- US Department of Health and Human Services. Healthy People 2010: what are its goals? Available from http://www.healthypeople.gov/About/goals.htm [Last accessed 4 April 2006]
- U.S. Valuation of the EuroQol EQ-5D Health States. Available from http://www.ahrq.gov/RICE/EQ5Dproj.htm [Last accessed 4 April 2006]
- Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 2005;43: 203–20
- Statistical Analysis Software [computer program]. Version 9.1. Cary, NC: SAS Institute Inc.; 2003
- SPSS for Windows [computer program]. Version 11.0. Chicago, IL: SPSS Inc.; 2001
- Gold MR, Muennig P. Measure-dependent variation in burden of disease estimates: implications for policy. Med Care 2002;40:260–6
- Myers JA, McPherson KM, Taylor WJ, et al. Duration of condition is unrelated to health-state valuation on the EuroQoL. Clin Rehabil 2003;17:209–15
- Dolan P. The effect of experience of illness on health state valuations. J Clin Epidemiol 1996;49:551–64
- Dolan P. Whose preferences count? Med Decis Making 1999;19:482–6
- Ubel PA, Richardson J, Menzel P. Societal value, the person trade-off, and the dilemma of whose values to measure for cost-effectiveness analysis. Health Econ 2000;9:127–36
- McPherson K, Myers J, Taylor WJ, et al. Self-valuation and societal valuations of health state differ with disease severity in chronic and disabling conditions. Med Care 2004;42:1143–51
- Badia X, Herdman M, Kind P. The influence of ill-health experience on the valuation of health. Pharmacoeconomics 1998;13:687–96